Zeskind Benjamin J. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$158,487.96
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Zeskind Benjamin J.

According to the SEC Form 4 filings, Zeskind Benjamin J., being in a position of

  1. PRESIDENT AND CEO at Immuneering Corporation,
    оver the last 12 months, has bought 2400 shares for $10,948, and sold 0 shares,
    over all time since 2021-08-03, has bought 60581 share for $254,459, and sold 0 shares.

Biography of Zeskind Benjamin J.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $10,9481100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-06-23PurchaseImmuneering Corporation
IMRX
PRESIDENT AND CEO
2,400
0.0066%
$4.56$10,948-1.76%
2025-07-02PurchaseImmuneering Corporation
IMRX
PRESIDENT AND CEO
7,015
0.0192%
$3.53$24,792+46.8%
2025-07-01PurchaseImmuneering Corporation
IMRX
PRESIDENT AND CEO
2,985
0.0081%
$3.38$10,087+53.2%
2025-06-18PurchaseImmuneering Corporation
IMRX
PRESIDENT AND CEO
21,000
0.0503%
$2.39$50,144+90.25%
2024-03-19PurchaseImmuneering Corporation
IMRX
PRESIDENT AND CEO
20,000
0.0735%
$2.77$55,326-31.32%
2022-03-23PurchaseImmuneering Corporation
IMRX
PRESIDENT AND CEO
3,000
0.0119%
$8.02$24,060-18.85%
2021-09-13PurchaseImmuneering Corporation
IMRX
PRESIDENT AND CEO
2,083
0.0111%
$22.87$47,632-67.66%
2021-08-03PurchaseImmuneering Corporation
IMRX
President and CEO
2,098
0.009%
$15.00$31,470-47.84%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.